Analyst Ranking
Bottom 4%
#4710 out of 4873 analysts
Average Return
-9.72%
Win Rate
32%35 out of 111
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+460.24%$0.83$4.65
2024-08-13 -
2025-05-08
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-04 -
2021-02-05
Buy
Lantheus Holdings IncLNTH
+67.88%$64.32$107.98
2023-11-02 -
2024-11-01
Buy
Paragon 28 IncFNA
+58.67%$8.25$13.09
2024-05-08 -
2025-04-17
Buy
Si Bone IncSIBN
+34.91%$12.69$17.12
2022-11-07 -
2023-11-07
Buy

David Turkaly Analyst Color

Get additional color on David Turkaly's coverage of popular stocks

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Zimmer Biomet Holdings IncZBH
11Buy$125.00+31.43%Maintains
2 days ago
Crowdstrike Holdings IncCRWD
1Buy$500.00+16.65%Maintains
4 days ago
Steris PLCSTE
14Buy$265.00+17.33%Reiterates
a month ago
Tela Bio IncTELA
6Buy$7.00+606.36%Maintains
2 months ago
Orthopediatrics CorpKIDS
10Buy$50.00+116.64%Reiterates
2 months ago
Axogen IncAXGN
5Buy$26.00+106.51%Reiterates
2 months ago
Integra Lifesciences Holdings CorpIART
12Buy$35.00+171.53%Reiterates
2 months ago
Si Bone IncSIBN
6Buy$32.00+74.58%Reiterates
2 months ago
Haemonetics CorpHAE
8Buy$100.00+47.04%Maintains
3 months ago
Snap IncSNAP
1Buy$16.00+94.65%Reiterates
3 months ago
Lantheus Holdings IncLNTH
8Buy$112.00+39.23%Reiterates
4 months ago
Enovis CorpENOV
1Buy$62.00+87.42%Initiates Coverage On
7 months ago
Neuronetics IncSTIM
4Buy$3.00-35.48%Maintains
9 months ago
Paragon 28 IncFNA
4Buy$20.00+52.79%Maintains
a year ago
Teleflex IncTFX
10Buy$285.00N/AReiterates
a year ago
Nevro CorpNVRO
5Buy$40.00N/AMaintains
2 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
2 years ago
Apyx Medical CorpAPYX
1Buy$14.00N/AMaintains
4 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.